The first in-vivo energy harvester ​designed to collect and store body's ​inherent energy to power medical devices.

Cardioelectric Technologies is a Greek development company that has ​pioneered innovative technology based on the principles of ​triboelectricity. This device aims to minimize the need for surgical ​interventions associated with battery replacements, thereby reducing ​patient complications and enhancing the longevity of medical implants.

cardio

electric

About

Cardioelectric Technologies emerged from a ​team of medical professionals who recognized ​the need for sustainable medical power ​solutions. The strength of the company lies in its ​experienced experts, whose combined ​knowledge drives innovation.

Nikolaos Anousakis-Vlachochristou

Cardiologist

Konstantinos Toutouzas

Cardiologist

Interventional cardiologist at Hippocration Hospital of Athens, experienced in percutaneous coronary ​interventions and structural heart procedures, he participates in clinical studies and educational programs.

Elias Siores

Physicist

Served as Provost and now Emeritus Professor of “Institute of Materials Research and Innovation” at the ​University of Bolton, he specializes in smart materials ​and energy harvesting technologies, contributing ​significantly to advancements in these fields.

Konstantinos Nanopoulos

Executive Director & Angel Investor

Financial advisor and tech entrepreneur with a strong academic background and international business ​practice, providing strategic direction and financial oversight.

Dimitris Kouzelis

Patent Attorney & General Counsel

European Patent Attorney, specializing in intellectual property strategy and patent prosecution.

Technology

The proprietary Cardioelectric Technologies ​device leverages the triboelectric effect, a ​phenomenon where certain materials become ​electrically charged when rubbed together. This ​effect is optimized for the in-vivo environment, ​making it particularly suitable for harvesting ​energy from the low-frequency movements of ​the human body, such as the beating of the heart ​and respiratory movements.

Optimized Design

Extensive proprietary research has led to the optimal design of the Cardioelectric ​device, ensuring it harnesses energy efficiently from the triboelectric effect.

In-Vivo Installation

Field studies have perfected the in-vivo installation process, making the device ​highly effective in real-world medical applications.

Maximum Efficiency

Commitment to research and innovation ensures the device operates at ​maximum efficiency, providing a dependable energy source for medical needs.

Applications

Cardioelectric Technologies is seeking to solve ​existing problems and open the path to ​applications that could not yet exist. This ​innovation not only enhances the longevity and ​reliability of implantable devices but also paves ​the way for new medical applications that were ​previously unfeasible due to power limitations. ​Through continuous research and development, ​Cardioelectric Technologies is committed to ​advancing healthcare solutions and improving ​patient outcomes.

PACEMAKER

Engagement

A lifelong solution to the fundamental problem of battery life and replacement risks.

Efficiency

Unlimited. The energy needs of any device are anticipated to be covered for the patient's lifetime.

Implantable Cardioverter Defibrillators

Engagement

A viable solution for the larger electricity needs of ICD devices.

Efficiency

Significantly more efficient than existing batteries, providing extended power supply life.

Neuro and Brain Stimulators

Engagement

New area of scientific and commercial research.

Efficiency

Expected high efficiency with a lifelong duration due to smaller energy consumption.

In-vivo Microcomputers

Engagement

In vivo data processing and storage, as the whole grail of futurism can be supported.

Efficiency

Use is limited to energy production.

Timeline

Developing innovative medical power generation ​technology requires dedicated effort and careful ​planning.

The Cardioelectric team of experts has diligently ​achieved key milestones and outlined the next ​steps in the development journey.

The current milestones include the successful ​invention of the technology and the submission of a ​patent application to protect this innovation.

The prototype development aims to be completed ​by the end of 2024. Following this, clinical trials ​will begin to validate the technology and prepare it ​for market readiness.

Investors are being sought to support the final ​stages of prototype development and subsequent ​clinical trials, ensuring the successful launch of ​the technology to market.

cardio

electric

Get in touch

+30 21 0724 5725

INFO@CARDIOELECTRIC.COM

VASILISSIS SOFIAS 62,

ATHENS 11528

GREECE

Cardioelectric Technologies is a privately held ​and funded company. Market participants and ​institutional investors interested in innovative ​solutions are welcome to connect.

Please fill out the form to initiate further ​discussions, and a response will be provided ​shortly.